• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控制财务变量——改变处方模式。

Controlling financial variables--changing prescribing patterns.

作者信息

Abramowitz P W

出版信息

Am J Hosp Pharm. 1984 Mar;41(3):503-15.

PMID:6367444
Abstract

Techniques of formulary management, pharmacy and therapeutics committee intervention, and the use of clinical pharmacy services to change prescribing patterns and contain costs in hospital pharmacy departments are reviewed. Methods of using the formulary to contain costs include deletion of generic and therapeutic equivalents, inclusion of therapeutic categories and cost codes, and regular reviews and updates of its contents. Drug monographs for formulary evaluation prepared for the P & T committee should include a comparative review of other drugs in the therapeutic category and a cost impact statement. The P & T committee can help contain costs by developing policies for automatic stop orders and restricted drug use. Clinical pharmacy activities that can result in cost savings include physician education (focused on prescribing), target drug programs, target disease programs, pharmacist participation on TPN and i.v. therapy teams, and patient training programs for home care. A matrix for evaluating cost-containment activities is presented. By tailoring the described methods to departmental personnel resources and hospital needs, the pharmacy can be effective in controlling costs.

摘要

本文回顾了医院药房部门中处方集管理、药学与治疗学委员会干预以及利用临床药学服务来改变处方模式和控制成本的技术。利用处方集控制成本的方法包括删除通用名药物和治疗等效物、纳入治疗类别和成本代码,以及定期审查和更新其内容。为药学与治疗学委员会准备的用于处方集评估的药物专论应包括对治疗类别中其他药物的比较审查和成本影响声明。药学与治疗学委员会可以通过制定自动停药医嘱和限制药物使用的政策来帮助控制成本。能够节省成本的临床药学活动包括医师教育(侧重于处方)、目标药物项目、目标疾病项目、药师参与全胃肠外营养和静脉治疗团队,以及家庭护理患者培训项目。本文还给出了一个评估成本控制活动的矩阵。通过根据部门人员资源和医院需求调整所描述的方法,药房能够有效地控制成本。

相似文献

1
Controlling financial variables--changing prescribing patterns.控制财务变量——改变处方模式。
Am J Hosp Pharm. 1984 Mar;41(3):503-15.
2
Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.通过具有成本效益的第一代头孢菌素处方集改变医生的处方习惯。
Hosp Pharm. 1989 Jan;24(1):33-8.
3
Formulary management to reduce cost: P & T committee strategies.通过处方集管理降低成本:药品与治疗学委员会的策略
Hosp Formul. 1986 Apr;21(4):481-3, 488-92.
4
Involving physicians in efforts to control pharmaceutical expenditures.让医生参与到控制药品支出的工作中。
Med Interface. 1995 Aug;8(8):85-7, 90.
5
Cost savings achieved through cephalosporin use review and restriction.通过头孢菌素使用审查和限制实现成本节约。
Am J Hosp Pharm. 1986 Sep;43(9):2194-7.
6
Enhancing the role of physicians in the cost-effective use of pharmaceuticals.加强医生在药物成本效益使用方面的作用。
Hosp Formul. 1994 Apr;29(4):262-6, 273.
7
Pharmacy management strategies for responding to hospital reimbursement changes.
Am J Hosp Pharm. 1983 Sep;40(9):1489-92.
8
Improving pharmacy and therapeutics committee operations.改善药事与治疗学委员会的运作。
Am J Hosp Pharm. 1984 Sep;41(9):1767-77.
9
Antimicrobial formulary management: meeting the challenge in a health maintenance organization.抗菌药物处方集管理:在健康维护组织中应对挑战
Pharmacotherapy. 1991;11(1 ( Pt 2)):32S-35S.
10
An inside look at the UCLA P&T committee: how does it influence prescribing practices?
Hosp Formul. 1986 Feb;21(2):214-7.

引用本文的文献

1
Impact of Sugammadex Versus Neostigmine/Glycopyrrolate on Perioperative Efficiency.舒更葡糖钠与新斯的明/格隆溴铵对围手术期效率的影响
Clinicoecon Outcomes Res. 2020 Jan 31;12:69-79. doi: 10.2147/CEOR.S221308. eCollection 2020.
2
What Is a Formulary, Anyway? Part 2.那么,什么是药品处方集?第二部分。
Pharmacy (Basel). 2018 Jul 23;6(3):72. doi: 10.3390/pharmacy6030072.
3
Should hospital pharmacy drug budgets be the responsibility of each individual department in an institution, or should such budgets be controlled centrally by the pharmacy department?
医院药房药品预算应由机构中的每个独立科室负责,还是应由药房部门集中控制?
Can J Hosp Pharm. 2010 Jul;63(4):330-2. doi: 10.4212/cjhp.v63i4.939.
4
Prioritising drug and therapeutics committee (DTC) decisions: a national survey.药物与治疗学委员会(DTC)决策的优先级排序:一项全国性调查。
Pharm World Sci. 2007 Apr;29(2):90-6. doi: 10.1007/s11096-006-9074-y. Epub 2006 Dec 23.
5
A review of limited lists and formularies: are they cost-effective?有限清单和处方集的综述:它们具有成本效益吗?
Pharmacoeconomics. 1992 Mar;1(3):191-202. doi: 10.2165/00019053-199201030-00006.
6
Drug cost containment at a large teaching hospital.大型教学医院的药品成本控制
Pharmacoeconomics. 1992 May;1(5):377-82. doi: 10.2165/00019053-199201050-00009.
7
Pharmacoeconomic consequences of measurement and modification of hospital drug use.医院用药计量与调整的药物经济学后果
Pharmacoeconomics. 1992 Jul;2(1):15-33. doi: 10.2165/00019053-199202010-00004.
8
Initiation of clinical pharmacy in Greece.
Pharm World Sci. 1996 Dec;18(6):229-32. doi: 10.1007/BF00735964.
9
Quality control of hospital formularies.医院处方集的质量控制
Pharm Weekbl Sci. 1988 Aug 19;10(4):145-50. doi: 10.1007/BF01959422.
10
The effects of a low-cost intervention program on hospital costs.一项低成本干预项目对医院成本的影响。
J Gen Intern Med. 1992 Jul-Aug;7(4):411-7. doi: 10.1007/BF02599158.